Yun Mo

Yun Mo currently holds the position of Senior Director of Pharmaceutical Development at Mirum Pharmaceuticals, Inc., since January 2020, where key responsibilities include regulatory filing of Livmarli® for Alagille Syndrome and PFIC, as well as addressing FDA and EMA inquiries regarding process development and validation. Prior experience includes serving as Senior Director of Product Development at Nuvation Bio and Director of Pharmaceutical Development at Axovant Sciences, focusing on analytical skills and cross-functional team leadership. Previously, Yun Mo worked as Associate Director of Drug Product Development at Biotie Therapies and as Group Leader of Pharmaceutical Development at Theravance Biopharma, contributing to multiple New Drug Applications. Educational credentials include a Ph.D. in Pharmaceutical Sciences from the National University of Singapore and a Post-Doc fellowship in gene delivery for ocular degeneration from the University of Nebraska Medical Center.